# 18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

> **NCT02717572** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 19 (actual)

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **RADIATION:** Fludeoxyglucose F 18
- **DEVICE:** Positron Emission Tomography
- **DEVICE:** Computerized Tomography
- **DEVICE:** Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT02717572
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-01
- **Primary completion:** 2017-06-05
- **Final completion:** 2017-06-05
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02717572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02717572, "18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02717572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*